BRISBANE, Australia, Aug. 12, 2021 /PRNewswire/ Treatment with diabetes drug canagliflozin lowers the PromarkerD risk score for developing diabetic kidney disease in patients with type 2
/PRNewswire/ El tratamiento con el fármaco para la diabetes canagliflozina disminuye la puntuación de riesgo PromarkerD de desarrollar enfermedad renal.
Diabetes treatment lowers PromarkerD risk score for diabetic kidney disease fnarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fnarena.com Daily Mail and Mail on Sunday newspapers.